BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28417551)

  • 21. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
    Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
    Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group.
    Cash T; McIlvaine E; Krailo MD; Lessnick SL; Lawlor ER; Laack N; Sorger J; Marina N; Grier HE; Granowetter L; Womer RB; DuBois SG
    Pediatr Blood Cancer; 2016 Oct; 63(10):1771-9. PubMed ID: 27297500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Latino and non-Latino patients with Ewing sarcoma.
    Sharib J; Horvai A; Gray Hazard FK; Daldrup-Link H; Goldsby R; Marina N; DuBois SG
    Pediatr Blood Cancer; 2014 Feb; 61(2):233-7. PubMed ID: 23970433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
    Mora J; Castañeda A; Perez-Jaume S; Lopez-Pousa A; Maradiegue E; Valverde C; Martin-Broto J; Garcia Del Muro X; Cruz O; Cruz J; Martinez-Trufero J; Maurel J; Vaz MA; de Alava E; de Torres C
    Br J Cancer; 2017 Sep; 117(6):767-774. PubMed ID: 28787430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
    Devadas SK; Banavali S
    Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
    Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ;
    Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
    Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U
    Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole lung irradiation for adults with pulmonary metastases from Ewing sarcoma.
    Casey DL; Alektiar KM; Gerber NK; Wolden SL
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1069-1075. PubMed ID: 25035210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the management of localized Ewing sarcoma in a developing country.
    Totadri S; Bansal D; Rao KLN; Jain R; Saxena AK; Kapoor R; Samujh R; Trehan A
    Pediatr Hematol Oncol; 2020 Oct; 37(7):610-619. PubMed ID: 32558608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
    Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
    J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
    Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
    Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Metastatic Site Irradiation in Pediatric Patients With Metastatic Ewing Sarcoma.
    Grewal AS; Li Y; Grewal SK; Bagatell R; Balamuth N; Womer R; Kurtz G; Tochner Z; Hill-Kayser CE
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e305-e309. PubMed ID: 32079986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of recurrence and survival after relapse in patients with Ewing sarcoma.
    Stahl M; Ranft A; Paulussen M; Bölling T; Vieth V; Bielack S; Görtitz I; Braun-Munzinger G; Hardes J; Jürgens H; Dirksen U
    Pediatr Blood Cancer; 2011 Oct; 57(4):549-53. PubMed ID: 21442722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
    Bhatia S; Krailo MD; Chen Z; Burden L; Askin FB; Dickman PS; Grier HE; Link MP; Meyers PA; Perlman EJ; Rausen AR; Robison LL; Vietti TJ; Miser JS
    Blood; 2007 Jan; 109(1):46-51. PubMed ID: 16985182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma.
    Scobioala S; Ranft A; Wolters H; Jabar S; Paulussen M; Timmermann B; Juergens H; Hassenpflug W; Klingebiel T; Elsayad K; Eich HT; Dirksen U
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):584-592. PubMed ID: 30244879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ewing Sarcoma: A 15-Year Experience of a Single Center With the MSKCC P6 Treatment Protocol.
    Ben-Ami T; Waldman E; Marc W; Weintraub M; Revel-Vilk S; Fried I
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):38-42. PubMed ID: 26670840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time to diagnosis of Ewing tumors in children and adolescents is not associated with metastasis or survival: a prospective multicenter study of 436 patients.
    Brasme JF; Chalumeau M; Oberlin O; Valteau-Couanet D; Gaspar N
    J Clin Oncol; 2014 Jun; 32(18):1935-40. PubMed ID: 24841977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma.
    Rasper M; Jabar S; Ranft A; Jürgens H; Amler S; Dirksen U
    Pediatr Blood Cancer; 2014 Aug; 61(8):1382-6. PubMed ID: 24729428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pelvis Ewing sarcoma: Local control and survival in the modern era.
    Ahmed SK; Robinson SI; Arndt CAS; Petersen IA; Haddock MG; Rose PS; Issa Laack NN
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28244685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.